Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 1;4(8):1011-1013.
doi: 10.34067/KID.0000000000000217.

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT

Justin M Belcher  1   2
Affiliations
Editorial

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT

Justin M Belcher. Kidney360. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

J.M. Belcher reports the following: Consultancy: Mallinckrodt Pharmaceuticals; Honoraria: Mallinckrodt Pharmaceuticals; and Advisory or Leadership Role: Mallinckrodt Pharmaceuticals.

Comment on

References

    1. Regner KR, Kanduri SR, Velez JCQ. Management of AKI in patients with cirrhosis. Curr Treat Opt Gastroenterol. 2022;20(3):295–315. doi:10.1007/s11938-022-00398-7 - DOI
    1. Velez JCQ, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol. 2020;16(3):137–155. doi:10.1038/s41581-019-0218-4 - DOI - PubMed
    1. Mattos AZ, Schacher FC, Mattos AA. Vasoconstrictors in hepatorenal syndrome- A critical review. Ann Hepatol. 2019;18(2):287–290. doi:10.1016/j.aohep.2018.12.002 - DOI - PubMed
    1. Belcher JM Parada XV Simonetto DA, et al. . Terlipressin and the treatment of hepatorenal syndrome: how the CONFIRM trial moves the story forward. Am J Kidney Dis. 2022;79(5):737–745. doi:10.1053/j.ajkd.2021.08.016 - DOI - PubMed
    1. Moore K Jamil K Verleger K, et al. . Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther. 2020;52(2):351–358. doi:10.1111/apt.15836 - DOI - PMC - PubMed

MeSH terms